Category Archives: Current Lawsuits & Investigations

Current Investment Fraud Lawsuits and Current Investment Fraud Investigations

AKORN, INC. LAWSUIT

AKORN, INC. LAWSUIT (AKRX)

Class Action Lawsuit Against Akorn, Inc. on Behalf of Akorn, Inc. Investors

JOIN THE AKORN, INC. LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

Akorn, Inc. Lawsuit Details
On March 4, 2015, a securities class action lawsuit was filed on behalf of purchasers of Akorn, Inc. (NASDAQ: AKRX)) common stock. The complaint alleges violations of federal securities laws,including alleging the issuance of materially false and misleading representations to the market which had the effect of artificially inflating the market price of the Company stock beginning April 17, 2014 through March 2, 2015.  The complaint alleges that Akorn failed to disclose it was lagging in integrating recent acquisitions into its accounting systems.

Akorn, Inc. Lawsuit

Akorn, Inc. Lawsuit

Legal Help for Akorn, Inc. Investors
If you purchased or otherwise acquired shares of Akorn, Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

ACCELERATE DIAGNOSTICS, INC LAWSUIT: (AXDX)

Class Action Lawsuit Against Accelerate Diagnostics, Inc. on Behalf of Accelerate Diagnostics, Inc. Investors

JOIN THE Accelerate Diagnostics, Inc. LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

Accelerate Diagnostics, Inc. Lawsuit Details
On March 19, 2015, a securities class action lawsuit was filed on behalf of purchasers of Accelerate Diagnostics, Inc. (NASDAQ: AXDX) common stock. Specifically, the complaint alleges violations of the federal securities laws, including alleging the issuance of material false and misleading representations to the market which had the effect of artificially inflating the market price of the Company stock beginning March 7, 2014 through February 17, 2015. The lawsuit alleges that the Company misrepresented the capability and description of its main product, the ID/AST system (formally known as the BACcel system).

Accelerate Diagnostics, Inc. Lawsuit Details Lawsuit

Accelerate Diagnostics, Inc. Lawsuit

Legal Help for Accelerate Diagnostics, Inc. Investors
If you purchased or otherwise acquired shares of Accelerate Diagnostics, Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

THE MEDICINES COMPANY INVESTIGATION

Gilman Law LLP is Investigating The Medicines Company on Behalf of Purchasers of The Medicines Company Stock

About the The Medicines Company
The Investment Fraud Attorneys of Gilman Law LLP announce they are investigating potential federal securities law claims on behalf of investors in The Medicines Company (NASDAQ:MDCO) common stock.

The Medicines Company Details of Investigation
On April 9, 2015, The Medicines Company announced that it expects net revenue in the range of $125 million to $140 million for the first quarter of 2015, which reflects a 29% to 26% decrease from the first quarter of 2014 due to lowering sales of Angiomax. The Company expects net revenue from sales of Angiomax to be in the range of $97 million to $105 million compared to $155.7 million in the first quarter of 2014. The Chairman and CEO of The Medicines Company, Clive Meanwell, stated that the declining sale of Angiomax “reflects our customers’ current uncertainty regarding the product’s patent exclusivity in the United States past June 2015” and that “[w]e appreciate our customers’ concerns about managing their pharmaceutical inventories.”

The Medicines Company

The Medicines Company Investigation

Legal Help for The Medicines Company Investors
If you purchased or otherwise acquired shares of The Medicines Company, you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please CALL TOLL FREE (888) 252-0048.

Polycom Inc. Investigation

POLYCOM, INC. INVESTIGATION

Gilman Law LLP is Investigating Polycom, Inc. on Behalf of Purchasers of Polycom, Inc. Stock

About the Polycom, Inc. Investigation
The Investment Fraud Attorneys of Gilman Law LLP announce they are investigating potential federal securities law claims on behalf of investors in Polycom, Inc. (NASDAQ: PLCM) common stock.

Polycom, Inc. Details of Investigation
The Securities and Exchange Commission (“SEC”) recently charged Polycom CEO Andrew Miller with using nearly $200,000 in corporate funds for personal perks that were not disclosed to investors, including travel to luxury resorts with his girlfriend.  Specifically, the SEC alleges that Miller engaged in a long-running scheme to surreptitiously use Polycom funds to pay for his personal expenses, including lavish meals, foreign and domestic travel, clothing, gifts and entertainment for himself, and his relatives and friends.  The SEC also alleges that from approximately 2010 until his resignation as CEO on July 19, 2013, Miller falsified, and caused others to falsify, business records in order to hide his scheme.  The SEC also alleges that Polycom repeatedly made misleading public statements to investors concerning such perquisites.

On July 23, 2013, Polycom announced that Miller had resigned and that the Company had found irregularities in Miller’s expense submissions, for which Miller had accepted responsibility.

Polycom Inc. Investigation

Polycom, Inc. Investigation

Legal Help for Polycom, Inc. Investors
If you purchased or otherwise acquired shares of Polycom, Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please CALL TOLL FREE (888) 252-0048.

Sonus Networks Lawsuit

SONUS NETWORKS LAWSUIT (SONS)

Class Action Lawsuit Against Sonus Networks on Behalf of Sonus Networks Investors

JOIN THE SONUS NETWORKS LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

Sonus Networks Lawsuit Details
Gilman Law LLP has announced that a federal securities class action lawsuit was filed on behalf of purchasers of Sonus Networks, Inc. (NASDAQ: SONS) common stock. The complaint alleges violations of federal securities laws, including alleging the issuance of materially false and misleading representations to the market which had the effect of artificially inflating the market price of the Company stock beginning October 23, 2014 through March 24, 2015.

The lawsuit alleges that Sonus made false and/or misleading statements and/or failed to disclose that: (1) the Company would be unable to close certain orders in the first quarter of 2015; and (2) the Company was experiencing longer decision cycles from its customers.

Sonus Networks Lawsuit

Sonus Networks Lawsuit

Legal Help for Sonus Networks Investors
If you purchased or otherwise acquired shares of Sonus Networks, you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

Willbros Group Inc. Lawsuit

WILLBROS GROUP INC. LAWSUIT (WG)

Class Action Lawsuit Against Willbros Group Inc. on Behalf of Willbros Group Inc. Investors

JOIN THE WILLBROS GROUP INC. LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

Willbros Group Inc. Lawsuit Details
Gilman Law LLP has announced that on March 4, 2015, a securities class action law suit was filed on behalf of investors in Willbros Group Inc. (NYSE: WG) common stock. The complaint alleges violations of the federal securities laws, including the issuance of materially false and misleading representations to the market which had the effect of artificially inflating the market price of the Company stock beginning August 4, 2013 through October 21, 2014. The complaint notes that on October 21, 2014, the Company announced that it would restate its 2nd Quarter 2014 results, and that the Company also announced that its Audit Committee was reviewing the adequacy of the Company’s internal controls.

Willbros Group Inc. Lawsuit

Willbros Group Inc. Lawsuit

Legal Help for Willbros Group Inc. Investors
If you purchased or otherwise acquired shares of Willbros Group Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

TCP INTERNATIONAL HOLDINGS LTD. LAWSUIT (TCPI)

Class Action Lawsuit Against TCP International Holdings Ltd. on Behalf of TCP International Holdings Ltd. Investors

JOIN THE TCP INTERNATIONAL HOLDINGS LTD. LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

TCP International Holdings Ltd. Lawsuit Details
Gilman Law LLP has announced that on March 2, 2015, a federal securities class action lawsuit was filed on behalf of purchasers of TCP International Holdings Ltd. (NASDAQ: TCPI) common stock issued in connection with its IPO on June 26, 2014 or stock acquired between the IPO and February 27, 2015. The complaint alleges, among other matters, that the registration statement for the IPO contained inaccurate statements or omitted to disclose deficiencies in the Company’s disclosure controls and procedures.

TCP INTERNATIONAL HOLDINGS LTD. Lawsuit

Legal Help for TCP International Holdings Ltd. Investors
If you purchased or otherwise acquired shares of TCP International Holdings Ltd., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

Inogen, Inc. Lawsuit

INOGEN, INC. LAWSUIT (INGN)

Class Action Lawsuit Against Inogen, Inc. on Behalf of Inogen, Inc. Investors

JOIN THE Inogen, Inc. LAWSUIT CLICK HERE TO RECOVER YOUR LOSSES AND OBTAIN AN INVESTOR CERTIFICATION

Inogen, Inc. Lawsuit Details
Gilman Law LLP has announced that on March 19, 2015, a securities class action lawsuit was filed on behalf of purchasers of Inogen, Inc.(NASDAQ: INGN) common stock. The complaint alleges violations of the federal securities laws, including the issuance of materially false and misleading representations to the market which had the effect of artificially inflating the market price of the company stock beginning November 12, 2014 through March 11, 2015. According to the complaint, on March 11, 2015, the Company announced management had discovered potential accounting matters, which prompted the Company’s Audit Committee, with advisors, to commence an internal investigation.

Inogen, Inc. Lawsuit

Inogen, Inc. Lawsuit

Legal Help for Inogen, Inc. Investors
If you purchased or otherwise acquired shares of Inogen, Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.

About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.

For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.

INLAND AMERICAN REIT LAWSUIT INVESTIGATION

Gilman Law LLP, a leading shareholder rights and securities fraud law firm, is investigating alleged violations of federal securities laws on behalf of investors in Inland American Real Estate Trust, Inc. (Inland American REIT). Inland American focuses on acquiring and developing a diversified portfolio of commercial real estate including retail, multi-family, industrial, lodging, office and student housing properties, located in the United States and Canada.

Join the Inland American REIT Lawsuit | Contact a Securities Fraud Attorney

Inland American REIT Lawsuit

Inland American REIT Lawsuit

The Inland American REIT investigation focuses on the company’s recent announcement that it is being investigated by the Securities and Exchange Commission. The Inland American SEC Investigation involves potential violations of federal securities laws relating to Inland American’s fees and administration. Inland American REIT Investors and individuals with information related to this investigation are encouraged to contact Gilman Law LLP toll free at (888) 252-0048.

About Inland American REIT

Inland American is the largest non-traded REIT, with $11.2 billion in assets. Recently, Inland American disclosed in its quarterly report that the Securities & Exchange Commission (SEC) had initiated an investigation into the Inland American REIT. The investigation seeks “to determine whether there have been violations of certain provisions of the federal securities laws.” The potential violations at issue were described by the company as “regarding the business manager fees, property management fees, transactions with affiliates, timing and amount of distributions paid to investors, determination of property impairments, and any decision regarding whether the company might become a self-administered REIT.”

Problems with Non-Traded REITs

Inland American REIT, like many non-traded REITs, recently announced a reduction in its per share value, which has dropped down to $7.22 per share, a significantly reduction from the REIT’s initial offering price of $10 per share.

About Gilman Law LLP and Our Investment Fraud Attorneys

Gilman Law LLP is an investment fraud law firm with over 35 years of experience in securities litigation, complex securities matters, shareholder disputes, securities fraud, and other types of business and financial fraud. Our Investment Fraud Attorneys are offering Free Consultations to Inland American REIT Investors by calling toll free at (888) 252-0048.

TVIX LAWSUIT (VELOCITYSHARES 2X VIX SHORT)

Class Action Lawsuit Against Credit Suisse on Behalf of TVIX Investors in VelocityShares Daily 2x VIX Short ETN

About the TVIX Lawsuit

VelocityShares TVIX Lawsuit

VelocityShares TVIX Lawsuit

The Investment Fraud Attorneys of Gilman Law LLP announce that a class action lawsuit has been filed against Credit Suisse on Behalf of Investors in TVIX exchange traded notes (TVIX ETN) (NYSE:ARCA: TVIX). Investors who purchased or otherwise acquired shares in TVIX pursuant and/or traceable to a November 29, 2010 pricing supplement (together with a March 25, 2009 Registration Statement and Prospectus) and held TVIX ETNs through and including March 22, 2012 (Class Period), may have a claim to recover their losses in TVIX. TVIX ETNs were sold to investors during the Class Period by Credit Suisse AG and its affiliate Credit Suisse Securities (USA) LLC.

Legal Help for Investors with Losses in TVIX

  • Deadline: July 24, 2012
  • Class Period: November 29, 2010 – March 22, 2012
  • E-mail: kgilman@gilmanlawllp.com
  • Telephone: (888) 252-0048
  • Mail: 4001 Bonita Beach Rd., Suite 407, Bonita Springs, FL 40140

TVIX Lawsuit Details

Specifically, the complaint alleges that on February 21, 2012, Credit Suisse announced that it temporarily suspended further issuances of the TVIX ETNs due to “internal limits” reached on the size of the ETNs. As a result of the suspension, shares of TVIX subsequently traded at prices uncorrelated to the S&P VIX Short-term Futures index (the index that the ETN was purportedly designed to track through the use of VIX futures). This “disconnect” lasted for approximately one month.

On March 22, 2012, shares of TVIX declined in price by over 29% as rumors leaked into the market that Credit Suisse was considering whether to recommence issuance of the ETNs. On March 23, 2012, after Credit Suisse announced that it would reopen issuance of TVIX shares on a limited basis, shares of TVIX declined further by almost 40%.

The complaint alleges that these losses are a result of risks that were materially understated or omitted in the TVIX Offering Documents. Credit Suisse also misleadingly omitted to disclose necessary information and material risks of certain scenarios transpiring that might lead to large losses from investments in TVIX ETNs.

About our Investment Fraud Attorneys

The Securities Fraud Attorneys at Gilman Law LLP have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breaches of fiduciary duty, and other shareholder disputes.